Ajit P Varki

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Factors controlling the glycosylation potential of the Golgi apparatus
    A Varki
    Glycobiology Program, UCSD, La Jolla, USA
    Trends Cell Biol 8:34-40. 1998
  2. ncbi P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications
    A Varki
    Departments of Medicine and Pathology, Cancer Center and Glycobiology Research and Training Center, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093 0687, USA
    Braz J Med Biol Res 34:711-7. 2001
  3. ncbi N-glycolylneuraminic acid deficiency in humans
    A Varki
    Glycobiology Research and Training Center and Department of Medicine, University of California, San Diego, La Jolla, CA 92093 0687, USA
    Biochimie 83:615-22. 2001
  4. ncbi Six blind men and the elephant--the many faces of heparan sulfate
    Ajit Varki
    Glycobiology Research and Training Center, Department of Medicine, University of California at San Diego, La Jolla, CA 92093-0687, USA
    Proc Natl Acad Sci U S A 99:543-5. 2002
  5. ncbi Emerging opportunities and career paths for the young physician-scientist
    Ajit Varki
    Department of Medicine, Glycobiology Research and Training Center, University of California San Diego, La Jolla, California, USA
    Nat Med 8:437-9. 2002
  6. ncbi Human-specific regulation of alpha 2-6-linked sialic acids
    Pascal Gagneux
    Glycobiology Research and Training Center, Department of Medicine, University of California San Diego, La Jolla, California 92093-0687, USA
    J Biol Chem 278:48245-50. 2003
  7. ncbi Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis
    Lubor Borsig
    Glycobiology Research and Training Center and the Cancer Center, Department of Medicine and Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA 92093 0687, USA
    Proc Natl Acad Sci U S A 99:2193-8. 2002
  8. ncbi Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity
    Jennifer L Stevenson
    Glycobiology Research and Training Center, Department of Medicine, Biomedical Sciences Graduate Program, University of California, San Diego, La Jolla, California 92093-0687, USA
    Clin Cancer Res 11:7003-11. 2005
  9. ncbi System-wide genomic and biochemical comparisons of sialic acid biology among primates and rodents: Evidence for two modes of rapid evolution
    Tasha K Altheide
    Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California 92093-0687, USA
    J Biol Chem 281:25689-702. 2006
  10. ncbi Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas
    Mark Wahrenbrock
    Department of Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California 92093 0687, USA
    J Clin Invest 112:853-62. 2003

Collaborators

Detail Information

Publications67

  1. ncbi Factors controlling the glycosylation potential of the Golgi apparatus
    A Varki
    Glycobiology Program, UCSD, La Jolla, USA
    Trends Cell Biol 8:34-40. 1998
    ..Old and new approaches towards elucidating the organization of glycosylation machinery in the Golgi are also considered...
  2. ncbi P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications
    A Varki
    Departments of Medicine and Pathology, Cancer Center and Glycobiology Research and Training Center, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093 0687, USA
    Braz J Med Biol Res 34:711-7. 2001
    ..We therefore suggest that heparin use in cancer be re-explored, specifically during the time interval between initial visualization of a primary tumor until just after definitive surgical removal...
  3. ncbi N-glycolylneuraminic acid deficiency in humans
    A Varki
    Glycobiology Research and Training Center and Department of Medicine, University of California, San Diego, La Jolla, CA 92093 0687, USA
    Biochimie 83:615-22. 2001
    ..This review provides an update on this matter, and considers a variety of other old and new questions that arise from it...
  4. ncbi Six blind men and the elephant--the many faces of heparan sulfate
    Ajit Varki
    Glycobiology Research and Training Center, Department of Medicine, University of California at San Diego, La Jolla, CA 92093-0687, USA
    Proc Natl Acad Sci U S A 99:543-5. 2002
  5. ncbi Emerging opportunities and career paths for the young physician-scientist
    Ajit Varki
    Department of Medicine, Glycobiology Research and Training Center, University of California San Diego, La Jolla, California, USA
    Nat Med 8:437-9. 2002
  6. ncbi Human-specific regulation of alpha 2-6-linked sialic acids
    Pascal Gagneux
    Glycobiology Research and Training Center, Department of Medicine, University of California San Diego, La Jolla, California 92093-0687, USA
    J Biol Chem 278:48245-50. 2003
    ....
  7. ncbi Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis
    Lubor Borsig
    Glycobiology Research and Training Center and the Cancer Center, Department of Medicine and Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA 92093 0687, USA
    Proc Natl Acad Sci U S A 99:2193-8. 2002
    ..Thus, L-selectin on neutrophils, monocytes, and/or NK cells has a role in facilitating metastasis, acting beyond the early time points wherein P-selectin mediates interactions of platelet with tumor cells...
  8. ncbi Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity
    Jennifer L Stevenson
    Glycobiology Research and Training Center, Department of Medicine, Biomedical Sciences Graduate Program, University of California, San Diego, La Jolla, California 92093-0687, USA
    Clin Cancer Res 11:7003-11. 2005
    ..Caution is also raised about the current preference for smaller heparins. Despite equivalent anticoagulation, hitherto unsuspected benefits of selectin inhibition in various clinical circumstances may be unwittingly discarded...
  9. ncbi System-wide genomic and biochemical comparisons of sialic acid biology among primates and rodents: Evidence for two modes of rapid evolution
    Tasha K Altheide
    Glycobiology Research and Training Center, Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California 92093-0687, USA
    J Biol Chem 281:25689-702. 2006
    ....
  10. ncbi Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas
    Mark Wahrenbrock
    Department of Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California 92093 0687, USA
    J Clin Invest 112:853-62. 2003
    ..These data may also explain why heparin ameliorates Trousseau syndrome, while vitamin K antagonists that merely depress thrombin production do not...
  11. ncbi Human-specific expression of Siglec-6 in the placenta
    Els C M Brinkman-Van der Linden
    Glycobiology Research and Training Center, Department of Medicine, University of California at San Diego, La Jolla, CA 92093 0687, USA
    Glycobiology 17:922-31. 2007
    ..The leptin-binding ability of Siglec-6 is also consistent with this hypothesis, as leptin-deficient mice have increased parturition times...
  12. ncbi Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms
    Takashi Angata
    Glycobiology Research and Training Center, University of California at San Diego, La Jolla, CA 92093 0687, USA
    Proc Natl Acad Sci U S A 101:13251-6. 2004
    ....
  13. ncbi Colloquium paper: uniquely human evolution of sialic acid genetics and biology
    Ajit Varki
    Center for Academic Research and Training in Anthropogeny, Glycobiology Research and Training Center, Departments of Medicine and Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA
    Proc Natl Acad Sci U S A 107:8939-46. 2010
    ....
  14. ncbi Nothing in glycobiology makes sense, except in the light of evolution
    Ajit Varki
    Glycobiology Research and Training Center, Departments of Medicine and Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA 92093, USA
    Cell 126:841-5. 2006
    ..The remarkable structural diversity of glycans in nature, and their roles in cellular processes, host-pathogen interactions, biological diversity and speciation can be explained by evolutionary processes...
  15. ncbi Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis
    Mai Zhang
    Glycobiology Research and Training Center, Departments of Medicine and Cellular and Molecular Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093 0687, USA
    Glycobiology 14:939-49. 2004
    ..The effects on antibody-mediated endocytosis could be of relevance to immunotoxin treatment of lymphomas...
  16. ncbi Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells
    Muriel Bardor
    Glycobiology Research and Training Center, Department of Medicine, University of California San Diego, La Jolla, California, 92093-0687, USA
    J Biol Chem 280:4228-37. 2005
    ..The approach could, thus, potentially be generalized to any small molecule that has a specific lysosomal transporter but not a plasma membrane transporter...
  17. ncbi Trousseau's syndrome: multiple definitions and multiple mechanisms
    Ajit Varki
    University of California, San Diego, La Jolla CA 92093 0687, USA
    Blood 110:1723-9. 2007
    ....
  18. ncbi Siglecs--the major subfamily of I-type lectins
    Ajit Varki
    Research Center for Glycoscience, National Institute of Advanced Industrial Science and Technology, Tsukuba, Ibaraki 305 8568, Japan
    Glycobiology 16:1R-27R. 2006
    ..This article provides an overview of historical and current information about the Siglecs...
  19. ncbi Evolution of human-chimpanzee differences in malaria susceptibility: relationship to human genetic loss of N-glycolylneuraminic acid
    Maria J Martin
    Glycobiology Research and Training Center and Department of Medicine, University of California at San Diego, La Jolla, CA 92093, USA
    Proc Natl Acad Sci U S A 102:12819-24. 2005
    ..These results also have implications for the prehistory of hominids and for the genetic origins and recent emergence of P. falciparum as a major human pathogen...
  20. ncbi Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins
    Ajit Varki
    Department of Medicine, Glycobiology Research and Training Center, University of California at San Diego, La Jolla, California 92093 0687, USA
    Nature 446:1023-9. 2007
    ..Studying the roles of such proteins in vertebrates has improved our understanding of normal physiology, disease and human evolution...
  21. ncbi Comparing the human and chimpanzee genomes: searching for needles in a haystack
    Ajit Varki
    Glycobiology Research and Training Center, Departments of Medicine and Cellular and Molecular Medicine, University of California at San Diego, La Jolla, California 92093, USA
    Genome Res 15:1746-58. 2005
    ..These two approaches will intersect at many levels and should be considered complementary. We also cite some known genetic differences between humans and great apes, realizing that these likely represent only the tip of the iceberg...
  22. ncbi 9-O-acetylation of exogenously added ganglioside GD3. The GD3 molecule induces its own O-acetylation machinery
    Helen Y Chen
    Glycobiology Research and Training Center, Department of Medicine, University of California San Diego, La Jolla, California 92093-0687, USA
    J Biol Chem 281:7825-33. 2006
    ....
  23. ncbi A uniquely human consequence of domain-specific functional adaptation in a sialic acid-binding receptor
    Justin L Sonnenburg
    Glycobiology Research and Training Center, Department of Medicine, University of California, San Diego, La Jolla, CA 92093 0687, USA
    Glycobiology 14:339-46. 2004
    ..Such domain-specific divergences should also be considered in upcoming comparisons of human and chimpanzee genomes...
  24. ncbi Diversity in cell surface sialic acid presentations: implications for biology and disease
    Nissi M Varki
    Department of Pathology, Glycobiology Research and Training Center, University of California at San Diego, La Jolla, CA 92093 0687, USA
    Lab Invest 87:851-7. 2007
    ..This review will provide some examples of these diverse roles of Sias and briefly address immunohistochemical approaches to their detection...
  25. ncbi Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans
    Nissi M Varki
    Department of Medicine, Cancer Center, University of California, San Diego, La Jolla, California 92093 0687, USA
    Semin Thromb Hemost 28:53-66. 2002
    ..A suggested clinical trial is outlined...
  26. ncbi Symbol nomenclature for glycan representation
    Ajit Varki
    Glycobiology Research and Training Center, University of California, San Diego, La Jolla, CA 92093 0687, USA
    Proteomics 9:5398-9. 2009
    ..We also note that >200 illustrations in the second edition have already been published using our nomenclature and are available for download at PubMed...
  27. ncbi Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia
    Takashi Angata
    Glycobiology Research and Training Center, Department of Medicine, University of California, San Diego, La Jolla, California 92093 0687, USA
    J Biol Chem 277:24466-74. 2002
    ....
  28. ncbi Loss of Siglec expression on T lymphocytes during human evolution
    Dzung H Nguyen
    Glycobiology Research and Training Center and Department of Medicine, University of California at San Diego, La Jolla, CA 92093, USA
    Proc Natl Acad Sci U S A 103:7765-70. 2006
    ....
  29. ncbi Explaining human uniqueness: genome interactions with environment, behaviour and culture
    Ajit Varki
    Center for Academic Research and Training in Anthropogeny, University of California, San Diego, La Jolla, California 92093, USA
    Nat Rev Genet 9:749-63. 2008
    ....
  30. ncbi Multiple changes in sialic acid biology during human evolution
    Ajit Varki
    Center for Academic Research and Training in Anthropogeny, Department of Medicine, University of California, San Diego, 9500 Gilman Dr MC 0687, La Jolla, CA 92093 0687, USA
    Glycoconj J 26:231-45. 2009
    ..As humans also have varying and sometime high levels of circulating anti-Neu5Gc antibodies, there are implications for biotechnology products, and for some human diseases associated with chronic inflammation...
  31. ncbi Sialic acids in human health and disease
    Ajit Varki
    Glycobiology Research and Training Center, Departments of Medicine and Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA 92093 0687, USA
    Trends Mol Med 14:351-60. 2008
    ..This review considers some examples of their established and newly emerging roles in aspects of human physiology and disease...
  32. ncbi Biomedical differences between human and nonhuman hominids: potential roles for uniquely human aspects of sialic acid biology
    Nissi M Varki
    Glycobiology Research and Training Center, University of California at San Diego, La Jolla, 92093 0687, USA
    Annu Rev Pathol 6:365-93. 2011
    ..We also discuss the metabolic incorporation of a diet-derived nonhuman sialic acid, which generates a novel xeno-autoantigen reaction, and chronic inflammation known as xenosialitis...
  33. ncbi The sialome--far more than the sum of its parts
    Miriam Cohen
    Glycobiology Research and Training Center, Department of Medicine, University of California, San Diego, La Jolla, California, USA
    OMICS 14:455-64. 2010
    ..Understanding the full complexity of the sialome thus requires combined analyses at multiple levels, that is, the sialome is far more than the sum of its parts...
  34. ncbi Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects
    Jennifer L Stevenson
    Glycobiology Research and Training Center, Departments of Medicine and Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA
    Thromb Res 120:S107-11. 2007
    ..However, such heparins could have further effects at higher doses...
  35. ncbi alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo
    Maria Hedlund
    Glycobiology Research and Training Center, Department of Medicine, University of California, San Diego, La Jolla, California 92093 0687, USA
    Cancer Res 68:388-94. 2008
    ..These findings indicate a role for ST6Gal-I as a mediator of tumor progression, with its expression causing a less differentiated phenotype, via enhanced beta1-integrin function...
  36. ncbi Discovery and characterization of sialic acid O-acetylation in group B Streptococcus
    Amanda L Lewis
    Division of Biological Sciences, Glycobiology Research and Training Center, University of California at San Diego, La Jolla, CA 92093-0687, USA
    Proc Natl Acad Sci U S A 101:11123-8. 2004
    ..Thus, our discovery has important implications for GBS pathogenicity, immunogenicity, and vaccine design...
  37. ncbi Innovations in host and microbial sialic acid biosynthesis revealed by phylogenomic prediction of nonulosonic acid structure
    Amanda L Lewis
    Glycobiology Research and Training Center, Departments of Pediatrics, School of Medicine, University of California at San Diego, La Jolla, CA 92093, USA
    Proc Natl Acad Sci U S A 106:13552-7. 2009
    ..Together, these data indicate that some of the long-standing paradigms in Sia biology should be reconsidered in a wider evolutionary context of the extended family of NulO sugars...
  38. ncbi Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response
    Aaron F Carlin
    Department of Medicine, Pediatrics, and Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093 0687, USA
    Blood 113:3333-6. 2009
    ..Thus, GBS can impair neutrophil defense functions by coopting a host inhibitory receptor via sialoglycan molecular mimicry, a novel mechanism of bacterial immune evasion...
  39. ncbi Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5
    Aaron F Carlin
    Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA
    J Exp Med 206:1691-9. 2009
    ..We conclude that protein-mediated functional engagement of an inhibitory host lectin receptor promotes bacterial innate immune evasion...
  40. ncbi Effects of sialic acid substitutions on recognition by Sambucus nigra agglutinin and Maackia amurensis hemagglutinin
    Els C M Brinkman-Van der Linden
    Glycobiology Research and Training Center, University of California at San Diego, La Jolla, CA 92093-0687, USA
    Anal Biochem 303:98-104. 2002
  41. ncbi Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective
    Takashi Angata
    Glycobiology Research and Training Center, Department of Medicine, University of California-San Diego, La Jolla, California 92093-0687, USA
    Chem Rev 102:439-69. 2002
  42. ncbi A human-specific gene in microglia
    Toshiyuki Hayakawa
    Glycobiology Research and Training Center, University of California at San Diego, La Jolla, CA 92093, USA
    Science 309:1693. 2005
    ..SIGLEC11 is expressed in human but not in chimpanzee brain microglia. Further studies will determine if this event was related to the evolution of Homo...
  43. ncbi CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice
    Els C M Brinkman-Van der Linden
    Department of Medicine, University of California, San Diego, La Jolla, California 92093 0687, USA
    Mol Cell Biol 23:4199-206. 2003
    ....
  44. ncbi Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation
    Laura T Martin
    Glycobiology Research and Training Center, Department of Medicine, University of California San Diego, La Jolla, California 92093, USA
    J Biol Chem 277:32930-8. 2002
    ..These data demonstrate selective regulation of sialylation and 9-O-acetylation, point to cell types with potential physiological defects in null animals, and show in vivo evidence for competition between Golgi enzymes...
  45. ncbi Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid
    Pam Tangvoranuntakul
    Glycobiology Research and Training Center, Departments of Medicine and Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA 92093-0687, USA
    Proc Natl Acad Sci U S A 100:12045-50. 2003
    ..Potential implications for human diseases are briefly discussed...
  46. ncbi Probing for masked and unmasked siglecs on cell surfaces
    Els C Brinkman-Van der Linden
    Departments of Medicine and Cellular Molecular Medicine, University of California-San Diego, School of Medicine, La Jolla, California 92093, USA
    Methods Enzymol 363:113-20. 2003
  47. ncbi Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2
    Virginia D Winn
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, California 94143, USA
    Endocrinology 150:452-62. 2009
    ..The functional significance of these novel observations may provide new insights into the pathogenesis of PE, and assaying the circulating levels of these proteins could have clinical utility for predicting and/or diagnosing PE...
  48. ncbi Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation
    Paula C Soto
    Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA
    J Immunol 184:4185-95. 2010
    ..Taken together, these data may help explain human propensities for diseases associated with excessive activation of the adaptive immune system...
  49. ncbi The ethics of research on great apes
    Pascal Gagneux
    Conservation and Research for Endangered Species, Zoological Society of San Diego, San Diego, California, USA
    Nature 437:27-9. 2005
  50. ncbi Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins
    Darius Ghaderi
    Glycobiology Research and Training Center, Department of Medicine and Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California, USA
    Nat Biotechnol 28:863-7. 2010
    ..Our findings may be relevant to improving the half-life, efficacy and immunogenicity of glycoprotein therapeutics...
  51. ncbi Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes
    Aaron F Carlin
    Department of Pediatrics, Division of Pharmacology and Drug Discovery, University of California, San Diego School of Medicine, Cellular and Molecular Medicine East, La Jolla, CA 92093 0687, USA
    J Bacteriol 189:1231-7. 2007
    ..Thus, production of Sia-capped bacterial polysaccharide capsules that mimic human cell surface glycans in order to engage CD33rSiglecs may be an example of a previously unrecognized bacterial mechanism of leukocyte manipulation...
  52. ncbi Sequencing the chimpanzee genome: insights into human evolution and disease
    Maynard V Olson
    University of Washington Genome Center, Department of Medicine, University of Washington, Seattle, Washington 98195, USA
    Nat Rev Genet 4:20-8. 2003
    ..Second, chimpanzee-human comparisons are likely to yield molecular insights into how new biological characteristics evolve--findings that might be relevant throughout the tree of life...
  53. ncbi ABO blood group glycans modulate sialic acid recognition on erythrocytes
    Miriam Cohen
    Glycobiology Research and Training Center, Departments of Medicine and Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA
    Blood 114:3668-76. 2009
    ..Thus, ABH antigens can noncovalently alter the presentation of other cell surface glycans to cognate-binding proteins, without themselves being a direct ligand...
  54. ncbi Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs
    Dzung H Nguyen
    Glycobiology Research and Training Center, University of California, San Diego, La Jolla, USA
    Exp Hematol 34:728-35. 2006
    ..CONCLUSIONS: Multiple CD33rSiglecs are expressed on normal and malignant myelomonoyctic cells. Targeting these Siglecs, possibly in combinations, could improve anti-CD33 antibody therapy or be used as an alternative to anti-CD33...
  55. ncbi Advances in the biology and chemistry of sialic acids
    Xi Chen
    Department of Chemistry, University of California, Davis, California 95616, USA
    ACS Chem Biol 5:163-76. 2010
    ..Research efforts not only will lead to a better understanding of the biological and pathological importance of sialic acids and their diversity but also could lead to the development of therapeutics...
  56. ncbi Characterization of the acid stability of glycosidically linked neuraminic acid: use in detecting de-N-acetyl-gangliosides in human melanoma
    Justin L Sonnenburg
    Glycobiology Research and Training Center, Department of Medicine, University of California, San Diego, La Jolla, California 92093-0687, USA
    J Biol Chem 277:17502-10. 2002
    ..These advances allowed us to detect covalently bound Neu in lipid extracts of a human melanoma tumor, providing the first chemical proof for naturally occurring de-N-acetyl-gangliosides...
  57. ncbi Generation of mice deficient for macrophage galactose- and N-acetylgalactosamine-specific lectin: limited role in lymphoid and erythroid homeostasis and evidence for multiple lectins
    Thandi M Onami
    Molecular Biology Section, Division of Biology, Cancer Center, University of California San Diego, La Jolla, CA 92093, USA
    Mol Cell Biol 22:5173-81. 2002
    ..Experiments are presented that indicate the existence of another galactose- and N-acetylgalactosamine-recognizing lectin distinct from mMGL. This may explain the absence of a strong phenotype in mMGL-deficient mice...
  58. ncbi Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins
    Lianchun Wang
    Department of Cellular and Molecular Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093 0687, USA
    J Clin Invest 110:127-36. 2002
    ..Such analogs may prove useful as therapeutically effective inhibitors of inflammation...
  59. ncbi Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils
    Mai Zhang
    Glycobiology Research and Training Center, Departments of Medicine and Cellular and Molecular Medicine, and Biomedical Sciences Graduate Program, University of California at San Diego, La Jolla, CA 92093 0687, USA
    Blood 109:4280-7. 2007
    ....
  60. ncbi Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells
    Dzung H Nguyen
    Glycobiology Research and Training Center, and Department of Medicine, University of California at San Diego, La Jolla, CA 92093, USA
    J Immunol 175:228-36. 2005
    ..Further studies are needed to determine whether deposition of natural GcIg and complement can also target healthy proliferating immune cells for death in vivo following incorporation of dietary Neu5Gc...
  61. ncbi Overview of glycoconjugate analysis
    Ajit Varki
    University of California San Diego, La Jolla, California, USA
    Curr Protoc Protein Sci . 2009
    ..A glossary of terms used in glycobiology is also provided...
  62. ncbi Recombinant influenza C hemagglutinin-esterase as a probe for sialic acid 9-O-acetylation
    Laura T Martin
    Departments of Medicine and Cellular Molecular Medicine, University of California-San Diego, School of Medicine, La Jolla, California 92093, USA
    Methods Enzymol 363:489-98. 2003
  63. ncbi NeuA sialic acid O-acetylesterase activity modulates O-acetylation of capsular polysaccharide in group B Streptococcus
    Amanda L Lewis
    Glycobiology Research and Training Center, Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093 0687, USA
    J Biol Chem 282:27562-71. 2007
    ....
  64. ncbi O-acetylation of GD3: an enigmatic modification regulating apoptosis?
    Helen Y Chen
    Glycobiology Research and Training Center, Department of Medicine and Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA
    J Exp Med 196:1529-33. 2002
  65. ncbi Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution
    Hsun Hua Chou
    Glycobiology Research and Training Center, Department of Medicine, University of California at San Diego, La Jolla, CA 92093 0687, USA
    Proc Natl Acad Sci U S A 99:11736-41. 2002
    ..1-2.2 mya. In this regard, it is of interest that although Neu5Gc is the major sialic acid in most organs of the chimpanzee, its expression is selectively down-regulated in the brain, for as yet unknown reasons...
  66. ncbi Multiple hepatic receptors cooperate to eliminate secretory mucins aberrantly entering the bloodstream: are circulating cancer mucins the "tip of the iceberg"?
    Mark G Wahrenbrock
    Glycobiology Research and Training Center, Department of Medicine, University of California, San Diego, California 92093-0687, USA
    Cancer Res 66:2433-41. 2006
    ..quot; Such aberrantly circulating mucins could play pathologic roles not only in cancer but also during injury or inflammation of hollow organs and in liver disease...
  67. ncbi Blasts from the past
    Paul A Insel
    J Clin Invest 114:1017-33. 2004
    ....